ELSO

Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference

Retrieved on: 
Thursday, September 28, 2023
Face, Food and Drug Administration, ART, CPB, Research, Extracorporeal Life Support Organization, Inspira Health Network, ELSO, Hospital, Patient, OXY, FDA, Health, Conference, Food, Medical device, Pharmaceutical industry

RA'ANANA, Israel, Sept. 28, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care by empowering breathing without lungs, is proud to announce the unveiling of its INSPIRA ART line at the Extracorporeal Life Support Organization (ELSO) Conference in Seattle, WA.

Key Points: 
  • The ELSO conference brings together healthcare institutions, researchers, and industry partners
    RA'ANANA, Israel, Sept. 28, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.
  • Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care by empowering breathing without lungs, is proud to announce the unveiling of its INSPIRA ART line at the Extracorporeal Life Support Organization (ELSO) Conference in Seattle, WA.
  • ELSO is dedicated to improving a special type of life support called extracorporeal life support, which involves using external devices to support patients with severe breathing and/or heart problems.
  • Inspira will be introducing its new INSPIRA ART device line, revealing the INSPIRA ART100 device at ELSO, which marks a significant achievement by its team of experts.

Inspira™ Technologies Reports Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 10, 2023
Shekel, IPO, Human, Marketing, Risk, Research, Extracorporeal Life Support Organization, ELSO, Patient, Blood, OXY, Artificial intelligence, Unitary state, FDA, Annual report, Regulation of tobacco by the U.S. Food and Drug Administration, Conference, Food, Medical device, Pharmaceutical industry, Cryptocurrency, Security (finance), Proton Inspira

RA'ANANA, Israel, Aug. 10, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a company aiming to revolutionize acute respiratory care, announced today its financial results for the second quarter ended June 30, 2023.

Key Points: 
  • Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a company aiming to revolutionize acute respiratory care, announced today its financial results for the second quarter ended June 30, 2023.
  • "We are extremely pleased with our progress in the second quarter of 2023," said Dagi Ben-Noon, Chief Executive Officer of Inspira.
  • Sales and marketing expenses for the three months ended June 30, 2023 were $233,000, a decrease of approximately $72,000 compared to the second quarter of 2022.
  • General and administrative expenses for the three months ended June 30, 2023, were $1 million, a decrease of $400,000 compared to the second quarter of 2022.

Nicklaus Children's Hospital Recognized as a Gold Level Center for Excellence in Life Support

Retrieved on: 
Wednesday, August 2, 2023
Nicklaus Children's Hospital, Communication, Pediatric intensive care unit, Education, MSN, Extracorporeal membrane oxygenation, BSN, Extracorporeal Life Support Organization, ELSO, Patient, Gold, Pediatrics, Hospital, Health, Environment, PICU, National Intrepid Center of Excellence, Nursing

MIAMI, Aug. 2, 2023 /PRNewswire/ -- Nicklaus Children's Hospital has been recognized as a recipient of the Gold Level ELSO Award for Excellence in Life Support from the Extracorporeal Life Support Organization (ELSO).

Key Points: 
  • MIAMI, Aug. 2, 2023 /PRNewswire/ -- Nicklaus Children's Hospital has been recognized as a recipient of the Gold Level ELSO Award for Excellence in Life Support from the Extracorporeal Life Support Organization (ELSO).
  • The award highlights programs that have distinguished themselves by having processes and procedures that promote excellence and exceptional care in extracorporeal membrane oxygenation.
  • Extracorporeal Life Support Services are provided through the Pediatric Intensive Care Unit (PICU) at Nicklaus Children's, the leading pediatric care facility in South Florida.
  • "Gold Level recognition is a tribute to the commitment and excellence of the Nicklaus Children's PICU clinical team," said Nicklaus Children's Hospital Vice President and Chief Nursing Officer Shannon Odell, MSN, BSN, RNC-OB, NE-BC.

Memorial Regional Hospital Recognized for the Capabilities and Outcomes of its ECMO Program

Retrieved on: 
Tuesday, November 29, 2022
Blood, ELSO, Heart, Pemberton v. Tallahassee Memorial Regional Center, Hospital, Memorial Hermann Health System, Cardiogenic shock, Health, Patient, Cardiovascular disease, Education, Center of excellence, Heart failure, Critical care, Gold, Nursing, ECMO, Extracorporeal membrane oxygenation, Extracorporeal Life Support Organization, Jose B. Lingad Memorial Regional Hospital, Publication, Medicine, Medical device

HOLLYWOOD, Fla., Nov. 29, 2022 /PRNewswire-PRWeb/ -- Memorial Regional Hospital has been recognized by Extracorporeal Life Support Organization (ELSO) as a "Designated Gold Level Center of Excellence" for its extracorporeal membrane oxygenation (ECMO) program. The Memorial Healthcare System facility is one of only four adult hospitals in Florida to earn the recognition from the international society and the only program south of Orlando. The Center of Excellence designation requires re-application every 3 years, with this being the second consecutive Gold award for Memorial.

Key Points: 
  • HOLLYWOOD, Fla., Nov. 29, 2022 /PRNewswire-PRWeb/ -- Memorial Regional Hospital has been recognized by Extracorporeal Life Support Organization (ELSO) as a "Designated Gold Level Center of Excellence" for its extracorporeal membrane oxygenation (ECMO) program.
  • The Memorial Healthcare System facility is one of only four adult hospitals in Florida to earn the recognition from the international society and the only program south of Orlando.
  • The Center of Excellence designation requires re-application every 3 years, with this being the second consecutive Gold award for Memorial.
  • "Being recognized as a gold level Center of Excellence at Memorial Regional reflects the dedication to advancing healthcare that we continuously strive to achieve daily."

Professor Daniel Brodie, the President of the International Extracorporeal Organization (ELSO) and Director of Critical Care from New-York Columbia - Presbyterian Hospital, Has Joined Inspira Technologies' Advisory Board

Retrieved on: 
Wednesday, January 19, 2022
Coronavirus Scientific Advisory Board (Turkey), National Heart, Lung, and Blood Institute, The New England Journal of Medicine, Extracorporeal Life Support Organization, ART, Patient, Human, OXY, Journal, International, Inspira Health Network, Regulation of tobacco by the U.S. Food and Drug Administration, SEC, Division, Executive Committee, Adult, Program, Risk, S-1 Executive Committee, Columbia, Oxygen, ELSO, Center, Lung, NHLBI, Acute respiratory distress syndrome, Nasdaq, American Medical Association, JAMA, Unitary state, Company, Hospital, Form, CE, Critical Care Medicine (journal), Critical care, Food, FDA, Lancet, Pharmaceutical industry, Medical device

Ltd.(Nasdaq: IINN) (Nasdaq: IINNW)(the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that Professor Daniel Brodie, an expert in critical care medicine and extracorporeal life support methods, has joined Inspira Technologies' Scientific Advisory Board.

Key Points: 
  • Ltd.(Nasdaq: IINN) (Nasdaq: IINNW)(the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that Professor Daniel Brodie, an expert in critical care medicine and extracorporeal life support methods, has joined Inspira Technologies' Scientific Advisory Board.
  • Prof. Brodie's appointment to the Scientific Advisory Board follows the appointments of Prof. Eddy Fan and Dr. Stephan Ledot, world-renowned key opinion leaders in intensive care medicine and extracorporeal life support.
  • Prof. Brodie is the Section Chief for Critical Care within the Division of Pulmonary, Allergy and Critical Care Medicine, the Director of the Adult ECMO Program and the Director of the Center for Acute Respiratory Failure at the Columbia University/New York-Presbyterian Hospital.
  • Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies, stated: "It is a great honor to have Professor Brodie on Inspira Technologies' Scientific Advisory Board.

Manufacturers to Gain Real-World Evidence from Largest Collection of ECMO Data

Retrieved on: 
Wednesday, July 1, 2020
Medicine, Medical equipment, Extracorporeal membrane oxygenation, Intensive care medicine, Membrane technology, ELSO, Extracorporeal, Health, Extracorporeal Life Support Organization

"Clinicians, industry, and regulators value real-world data and evidence to improve product development, develop new indications, and promote patient safety," said Christine Stead, Chief Executive Officer, ELSO.

Key Points: 
  • "Clinicians, industry, and regulators value real-world data and evidence to improve product development, develop new indications, and promote patient safety," said Christine Stead, Chief Executive Officer, ELSO.
  • "The ELSO Evidence Explorer from ArborMetrix provides a novel platform to rapidly and easily explore the real-world evidence from the largest collection of multi-national ECMO centers in the world."
  • "ELSO, as the worldwide leader in extracorporeal life support advocacy, sees tremendous value in the ELSO Evidence Explorer to improve ECMO care," said Matthew Paden, M.D., President-Elect, ELSO.
  • ELSO Evidence Explorer is available via annual subscription to ECMO manufacturers who are ELSO corporate members.

Hemovent to introduce innovative and recently CE-marked MOBYBOX® at ELSO annual meeting

Retrieved on: 
Monday, September 9, 2019
Biotechnology, Medical devices, Health, Cardiology, Medicine, Medical specialties, Health, Medical equipment, Membrane technology, Extracorporeal Life Support Organization, Extracorporeal membrane oxygenation, ELSO, Extracorporeal, ASAIO Journal

Hemovent GmbH announced today that it will introduce its MOBYBOX ECMO / ECLS system at the upcoming annual meeting of ELSO (Extracorporeal Life Support Organization) in Austin, Tex., Sept. 12-15.

Key Points: 
  • Hemovent GmbH announced today that it will introduce its MOBYBOX ECMO / ECLS system at the upcoming annual meeting of ELSO (Extracorporeal Life Support Organization) in Austin, Tex., Sept. 12-15.
  • There is very significant interest in MOBYBOX from the ELSO community, said Christof Lenz, a co-founder and CEO of Hemovent.
  • We will be exhibiting MOBYBOX at the ELSO annual meeting while preparing for the carefully controlled market introduction of MOBYBOX in Europe.
  • Hemovent is an emerging medical device company with a proprietary platform technology for heart and lung support.